# Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects

> **NCT00444561** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 184 (actual)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** pramlintide acetate

## Key facts

- **NCT ID:** NCT00444561
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2015-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00444561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00444561, "Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00444561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*